SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-024503
Filing Date
2019-04-12
Accepted
2019-04-12 17:17:01
Documents
1
Period of Report
2019-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11143
  Complete submission text file 0001209191-19-024503.txt   12466
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 111 TENTH AVENUE SUITE 200 NASHVILLE TN 37203
Business Address
Galante Joseph C (Reporting) CIK: 0001632384 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33637 | Film No.: 19747034